Why is Amerise BioScie falling/rising?

As of 11-Sep, Amerise Biosciences Ltd is experiencing a price increase, currently at 0.75, reflecting a rise of 0.05 or 7.14%. The stock has shown a positive performance today, outperforming its sector by 7.25%. Additionally, the stock's delivery volume has increased by 11.16% against the 5-day average, indicating rising investor participation. While the stock is currently above its 5-day and 20-day moving averages, it remains below its longer-term moving averages, suggesting mixed momentum. Over the past week, the stock has gained 1.35%, contrasting with a decline of 3.85% over the past month, while it has seen a significant year-to-date drop of 38.02%.
In the broader market context, the stock's recent performance has outpaced the Sensex, which has increased by 1.03% over the past week. However, the stock's longer-term performance remains concerning, with a year-to-date decline significantly worse than the benchmark's gain of 4.36%. This disparity highlights the challenges faced by Amerise Biosciences Ltd, particularly given its substantial drop over the past three years compared to the Sensex's growth. Overall, while the stock is currently rising, its historical performance and the broader market trends suggest caution for investors.